Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin

J Struct Biol. 2011 Apr;174(1):84-91. doi: 10.1016/j.jsb.2010.10.004. Epub 2010 Oct 19.

Abstract

Human serum albumin (HSA) has two primary binding sites for drug molecules. These sites selectively bind different dansylated amino acid compounds, which-due to their intrinsic fluorescence-have long been used as specific markers for the drug pockets on HSA. We present here the co-crystal structures of HSA in complex with six dansylated amino acids that are specific for either drug site 1 (dansyl-l-asparagine, dansyl-l-arginine, dansyl-l-glutamate) or drug site 2 (dansyl-l-norvaline, dansyl-l-phenylalanine, dansyl-l-sarcosine). Our results explain the structural basis of the site-specificity of different dansylated amino acids. They also show that fatty acid binding has only a modest effect on binding of dansylated amino acids to drug site 1 and identify the location of secondary binding sites.

MeSH terms

  • Arginine / analogs & derivatives
  • Arginine / metabolism
  • Asparagine / analogs & derivatives
  • Asparagine / metabolism
  • Dansyl Compounds / metabolism*
  • Glutamates / metabolism
  • Humans
  • Phenylalanine / metabolism
  • Protein Binding
  • Sarcosine / analogs & derivatives
  • Sarcosine / metabolism
  • Serum Albumin / metabolism*

Substances

  • Dansyl Compounds
  • Glutamates
  • Serum Albumin
  • dansyl-phenylalanine
  • dansylsarcosine
  • dansyl asparagine
  • dansyl-L-arginine
  • Phenylalanine
  • dansylglutamic acid
  • Asparagine
  • Arginine
  • Sarcosine